Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

XKON/327610 stock hub

XKON/327610 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

XKON/327610is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Korea New Exchange

Market data

Live price

Current market quote for this ticker.

Current price

XKON/327610

In the news

Latest news · XKON/327610

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-74.1

P25 n/aP50 n/aP75 n/a

ROIC-45.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All XKON/327610 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

138

Groups with data

Currency

KRW

Showing 138 of 138 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	KRW 5B
Price	KRW 585
Price currency	KRW
Sic	2836
Symbol	xkon/327610
Website	https://www.femtobiomed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-24.23%
FCF yield	-24.7%
P/B ratio	4.86x
P/S ratio	12.81x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBITDA Margin	-275.77%
Gross margin	30.54%
Gross Profit	KRW 119.1M
Net Income	KRW -1.2B
Pretax Margin	-310.32%
ROA	-41.65
ROCE	-108.1
ROE	-74.1
ROIC	-45.09

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-87.02%
Cagr3y	-62.27%
Cagr5y	-42.7%
Revenue Growth	-1.42x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.22
Assets	KRW 1.2B
Cash	KRW 319.5M
Current Assets	KRW 747.9M
Current Liabilities	KRW 61.1M
Equity	KRW 1B
Interest Coverage	-1,690.3
Liabilities	KRW 143M
Long Term Assets	KRW 423.1M
Long Term Liabilities	KRW 81.9M
Net Cash	KRW 319.5M
Net Cash By Market Cap	KRW 6.4
Net Debt Equity	KRW -0.31
Tangible Book Value	KRW 792.4M
Tangible Book Value Per Share	KRW 574
WACC	5.46

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	12.25
Inventory Turnover	2.42
Net Working Capital	KRW 367.4M
Quick ratio	6.32
Working Capital	KRW 686.9M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-87%
200-day SMA	2,924.6
3Y total return	-94.63%
50-day SMA	1,382.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-93.82%
All Time High	24,900
All Time High Change	-97.65%
All Time High Date	2021-08-04
All Time Low	360
All Time Low Change	62.5%
All Time Low Date	2026-03-23
ATR	127
Beta	0.22
Beta1y	-1.61
Beta2y	-0.69
Ch YTD	-79.62
High	595
High52	6,200
High52 Date	2025-06-13
High52ch	-90.56%
Low	585
Low52	360
Low52 Date	2026-03-23
Low52ch	62.5%
Ma50ch	-57.68%
Price vs 200-day SMA	-80%
RSI	32.27
RSI Monthly	30.6
RSI Weekly	30.55
Sharpe ratio	-1.65x
Sortino ratio	-2.1
Tr YTD	-79.62
Tr1m	-5.95%
Tr1w	27.17%
Tr3m	-79.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -1.2B
Operating margin	-307.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,490,911%
Net Borrowing	-61,050,000
Shares Insiders	47.39%
Shares Out	8,536,086

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -1.2B
Average Volume	25,112.8x
Bv Per Share	656.8
CAPEX	KRW -134.7M
Ch1m	-5.95
Ch1w	27.17
Ch1y	-87
Ch3m	-79.4
Ch3y	-94.63
Ch5y	-93.82
Ch6m	-79.72
Change	-1.68%
Change From Open	-1.68
Close	595
Days Gap	0
Depreciation Amortization	124,746,000
Dollar Volume	12,870
EBIT	KRW -1.2B
EBITDA	KRW -1.1B
EPS	KRW -876
F Score	1
FCF	KRW -1.2B
FCF Per Share	KRW -144
Financing CF	-61,050,000
Fiscal Year End	December
Founded	2,011
Investing CF	-230,639,000
Is Primary Listing	1
Last Split Date	2021-07-22
Last Split Type	Forward
Ma150	2,314.9
Ma150ch	-74.73%
Ma20	630.1
Ma20ch	-7.15%
Net CF	-1,390,307,000
Open	595
Position In Range	0
Ppne	172,956,000
Price Date	2026-03-30
Ptbv Ratio	6.3
Relative Volume	0x
Revenue	389,955,000x
Tr6m	-79.72%
Volume	22
Z Score	-7.29

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does XKON/327610 pay a dividend?

Capital-return profile for this ticker.

Performance

XKON/327610 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns XKON/327610?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+47.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

XKON/327610 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.3

Neutral momentum band

Price vs 200-day MA

-80.0%

50/200-day relationship not available

Beta (5Y)

0.22

Less volatile than the market

Sharpe ratio

-1.65

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About XKON/327610

Hub-level FAQ points readers to the deeper analysis pages.

What is the current xkon/327610 stock rating?

xkon/327610 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full xkon/327610 analysis?

The full report lives at /stocks/xkon/327610/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for xkon/327610?

The latest report frames xkon/327610 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the xkon/327610 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.